Oxidative stress and the pathogenesis of neurodegenerative disorders.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  International review of neurobiology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1016/S0074-7742(07)82016-2PMID 17678968
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Local neuroinflammation and the progression of Alzheimer’s disease

  2011cited by this paper
• CD4+ T cells from Copolymer-1 immunized mice protect dopaminergic neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.

  2007cited by this paper
• Ion channel blockade attenuates aggregated alpha synuclein induction of microglial reactive oxygen species: relevance for the pathogenesis of Parkinson’s disease

  2007cited by this paper
• Therapeutic immunization with a glatiramer acetate derivative does not alter survival in G93A and G37R SOD1 mouse models of familial ALS.

  2007cited by this paper
• Cyclooxygenase-2 mediates microglial activation and secondary dopaminergic cell death in the mouse MPTP model of Parkinson's disease

  2006cited by this paper
• Butovsky, O. et al. Glatiramer acetate fights against Alzheimer's disease by inducing dendritic-like microglia expressing insulin-like growth factor 1. Proc. Natl Acad. Sci. USA 103, 11784-11789

  2006cited by this paper
• The glutamate‐glutamine cycle as an inducible, protective face of macrophage activation

  2006cited by this paper
• An Inflammatory Pathomechanism for Parkinsons Disease

  2006cited by this paper
• An inflammatory pathomechanism for Parkinson's disease?

  2006cited by this paper
• A novel antioxidant N-acetylcysteine amide prevents gp120- and Tat-induced oxidative stress in brain endothelial cells.

  2006cited by this paper
• Glatiramer acetate fights against Alzheimer's disease by inducing dendritic-like microglia expressing insulin-like growth factor 1.

  2006cited by this paper
• Microglial inflammation in the parkinsonian substantia nigra: relationship to alpha-synuclein deposition

  2005cited by this paper
• Microglia activated by IL-4 or IFN-g differentially induce neurogenesis and oligodendrogenesis from adult stem / progenitor cells

  2005cited by this paper
• Mononuclear phagocytes in the pathogenesis of neurodegenerative diseases

  2005cited by this paper
• Induction of CD4+CD25+ regulatory T cells by copolymer-I through activation of transcription factor Foxp3.

  2005cited by this paper
• Nonsteroidal antiinflammatory drug use and the risk for Parkinson's disease

  2005cited by this paper
• NeuroAIDS: Contributions of the human immunodeficiency virus‐1 proteins tat and gp120 as well as CD40 to microglial activation

  2005cited by this paper
• Ablation of the Inflammatory Enzyme Myeloperoxidase Mitigates Features of Parkinson's Disease in Mice

  2005cited by this paper
• Immunology of HIV-1.

  2005cited by this paper
• HIV-1 viral proteins gp120 and Tat induce oxidative stress in brain endothelial cells.

  2005cited by this paper
• Protein aggregation, metals and oxidative stress in neurodegenerative diseases.

  2005cited by this paper
• Aggregated α‐synuclein activates microglia: a process leading to disease progression in Parkinson's disease

  2005cited by this paper
• Neuroinflammation in the pathogenesis of amyotrophic lateral sclerosis

  2005cited by this paper
• Oxidative stress signalling in Alzheimer's disease.

  2004cited by this paper
• Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs

  2004cited by this paper
• NADPH Oxidase Mediates Lipopolysaccharide-induced Neurotoxicity and Proinflammatory Gene Expression in Activated Microglia*

  2004cited by this paper
• Therapeutic immunization protects dopaminergic neurons in a mouse model of Parkinson's disease.

  2004cited by this paper
• Human Immunodeficiency Virus Type 1 gp120 Induces Apoptosis in Human Primary Neurons through Redox-Regulated Activation of Neutral Sphingomyelinase

  2004cited by this paper
• Increased cytotoxic potential of microglia from ALS‐transgenic mice

  2004cited by this paper
• Oxidative stress in neurodegeneration: cause or consequence?

  2004cited by this paper
• Genetic clues to the pathogenesis of Parkinson's disease

  2004cited by this paper
• Unraveling the mechanisms involved in motor neuron degeneration in ALS.

  2004cited by this paper
• The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementia

  2004cited by this paper
• Parkinson's Disease Mechanisms and Models

  2003cited by this paper
• Relevance of oxidative injury in the pathogenesis of motor neuron diseases

  2003cited by this paper
• Neurodegeneration in amyotrophic lateral sclerosis: the role of oxidative stress and altered homeostasis of metals.

  2003cited by this paper
• Effects of Oxidative and Nitrative Challenges on α-Synuclein Fibrillogenesis Involve Distinct Mechanisms of Protein Modifications*

  2003cited by this paper
• Human immunodeficiency virus type 1 Tat protein directly activates neuronal N-methyl-d-aspartate receptors at an allosteric zinc-sensitive site

  2003cited by this paper
• Immunomodulation by the copolymer glatiramer acetate

  2003cited by this paper
• Therapeutic vaccine for acute and chronic motor neuron diseases: Implications for amyotrophic lateral sclerosis

  2003cited by this paper
• Macrophage proteomic fingerprinting predicts HIV-1-associated cognitive impairment

  2003cited by this paper
• Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease.

  2003cited by this paper
• alpha-Synuclein locus triplication causes Parkinson's disease.

  2003cited by this paper
• Programmed cell death in amyotrophic lateral sclerosis.

  2003cited by this paper
• Molecular Pathways of Neurodegeneration in Parkinson's Disease

  2003cited by this paper
• The basic aspects of therapeutics in amyotrophic lateral sclerosis.

  2003cited by this paper
• Regulated Expression of Sodium‐dependent Glutamate Transporters and Synthetase: a Neuroprotective Role for Activated Microglia and Macrophages in HIV Infection?

  2003cited by this paper
• Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration

  2003cited by this paper
• α-Synuclein Locus Triplication Causes Parkinson's Disease

  2003cited by this paper
• ATM deficiency and oxidative stress: a new dimension of defective response to DNA damage.

  2002cited by this paper
• Neuro-inflammation as a therapeutic target in amyotrophic lateral sclerosis.

  2002cited by this paper
• HIV‐1‐Associated Dementia: A Metabolic Encephalopathy Perpetrated by Virus‐Infected and Immune‐Competent Mononuclear Phagocytes

  2002cited by this paper
• HIV-1-associated dementia: a basic science and clinical perspective.

  2002cited by this paper
• HIV-1 and the brain: connections between HIV-1-associated dementia, neuropathology and neuroimmunology.

  2002cited by this paper
• HIV-1 and the central nervous system.

  2002cited by this paper
• Oxidation-induced Misfolding and Aggregation of Superoxide Dismutase and Its Implications for Amyotrophic Lateral Sclerosis*

  2002cited by this paper
• Do oxidatively modified proteins cause ALS?

  2002cited by this paper
• Dual action of glatiramer acetate (Cop-1) in the treatment of CNS autoimmune and neurodegenerative disorders.

  2002cited by this paper
• Blockade of Microglial Activation Is Neuroprotective in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Mouse Model of Parkinson Disease

  2002cited by this paper
• Inflammatory processes in amyotrophic lateral sclerosis

  2002cited by this paper
• Human immunodeficiency virus (HIV) proteins in neuropathogenesis of HIV dementia.

  2002cited by this paper
• Active glycation in neurofibrillary pathology of Alzheimer disease: Nε-(Carboxymethyl) lysine and hexitol-lysine

  2001cited by this paper
• Genetics of sporadic ALS

  2001cited by this paper
• From charcot to lou gehrig: deciphering selective motor neuron death in als

  2001cited by this paper
• The role of phagocytes in HIV-related oxidative stress.

  2001cited by this paper
• Oxidative stress and neuroAIDS: triggers, modulators and novel antioxidants.

  2001cited by this paper
• Metalloproteinases in biology and pathology of the nervous system

  2001cited by this paper
• Clinical and pathological features of a parkinsonian syndrome in a family with an Ala53Thr α‐synuclein mutation

  2001cited by this paper
• Clinical and pathological features of a Parkinsonian syndrome in a family with an Ala53Thr alpha-synuclein mutation.

  2001cited by this paper
• Glutamate is a mediator of neurotoxicity in secretions of activated HIV-1-infected macrophages.

  2001cited by this paper
• Oxidative Damage Is the Earliest Event in Alzheimer Disease

  2001cited by this paper
• Induction of gp91-phox, a Component of the Phagocyte NADPH Oxidase, in Microglial Cells during Central Nervous System Inflammation

  2001cited by this paper
• Production of reactive oxygen species from aggregating proteins implicated in Alzheimer's disease, Parkinson's disease and other neurodegenerative diseases.

  2001cited by this paper
• Inhibition of the cyclooxygenase isoenzymes COX‐1 and COX‐2 provide neuroprotection in the MPTP‐mouse model of Parkinson's disease

  2001cited by this paper
• Pathways to neuronal injury and apoptosis in HIV-associated dementia

  2001cited by this paper
• Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease

  2001cited by this paper
• Active glycation in neurofibrillary pathology of Alzheimer disease: N(epsilon)-(carboxymethyl) lysine and hexitol-lysine.

  2001cited by this paper
• Oxidative injury in diseases of the central nervous system: focus on Alzheimer's disease.

  2000cited by this paper
• New consensus research on neuropathological aspects of familial amyotrophic lateral sclerosis with superoxide dismutase 1 (SOD1) gene mutations: Inclusions containing SOD1 in neurons and astrocytes

  2000cited by this paper
• Decreasing incidence of CNS AIDS-defining events associated with antiretroviral therapy

  2000cited by this paper
• Dityrosine cross-linking promotes formation of stable alpha -synuclein polymers. Implication of nitrative and oxidative stress in the pathogenesis of neurodegenerative synucleinopathies.

  2000cited by this paper
• Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions.

  2000cited by this paper
• T cell immunity to copolymer 1 confers neuroprotection on the damaged optic nerve: possible therapy for optic neuropathies.

  2000cited by this paper
• Dityrosine Cross-linking Promotes Formation of Stable α-Synuclein Polymers

  2000cited by this paper
• Current status of SOD1 mutations in familial amyotrophic lateral sclerosis.

  2000cited by this paper
• Glutathione metabolism in brain metabolic interaction between astrocytes and neurons in the defense against reactive oxygen species.

  2000cited by this paper
• Neuronal oxidative stress precedes amyloid-beta deposition in Down syndrome.

  2000cited by this paper
• Neuronal Oxidative Stress Precedes Amyloid‐β Deposition in Down Syndrome

  2000cited by this paper
• Superoxide dismutase-1 mutation-related neurotoxicity in familial amyotrophic lateral sclerosis

  2000cited by this paper
• Primary macrophages infected by human immunodeficiency virus trigger CD95‐mediated apoptosis of uninfected astrocytes

  2000cited by this paper
• Glutathione metabolism in brain

  2000cited by this paper
• Specific Th2 cells accumulate in the central nervous system of mice protected against experimental autoimmune encephalomyelitis by copolymer 1.

  2000cited by this paper
• HIV-1 infected mononuclear phagocyte secretory products affect neuronal physiology leading to cellular demise: relevance for HIV-1-associated dementia.

  2000cited by this paper
• Review: history of the amyloid fibril.

  2000cited by this paper
• Role of immune-derived diffusible mediators in AIDS-associated neurological disorders.

  2000cited by this paper
• Neuronal Fractalkine Expression in HIV-1 Encephalitis: Roles for Macrophage Recruitment and Neuroprotection in the Central Nervous System1

  2000cited by this paper
• Population biology of HIV-1 infection: viral and CD4+ T cell demographics and dynamics in lymphatic tissues.

  1999cited by this paper
• RNA Oxidation Is a Prominent Feature of Vulnerable Neurons in Alzheimer’s Disease

  1999cited by this paper
• The amino-terminus of the amyloid-beta protein is critical for the cellular binding and consequent activation of the respiratory burst of human macrophages.

  1999cited by this paper
• Biological chemistry of copper-zinc superoxide dismutase and its link to amyotrophic lateral sclerosis.

  1999cited by this paper

• Roles of Reactive Oxygen Species in Relationships Between Viral Infections and Alzheimer’s Disease and Related Dementia

  2026cites this paper
• Neuropeptide S Protects Dopaminergic Neurons in a Paraquat-Induced Parkinson’s Model Using SH-SY5Y Cells

  2026cites this paper
• An ALS-associated mutant SOD1 protein can be eliminated in microglia culture by selective autophagy.

  2026cites this paper
• How is the brain affected by metabolically healthy or unhealthy obesity in adulthood and elderly? A narrative review of neuroimaging and neurocognitive findings

  2025cites this paper
• The link between early-life adversity and later alcohol use disorder: A role for microglia?

  2025cites this paper
• Association between dapagliflozin and risk of dementia and Parkinson's disease: a subgroup analysis of a meta-analysis of randomized controlled trials.

  2025cites this paper
• Neuroprotective Effect of Mixed Mushroom Mycelia Extract on Neurotoxicity and Neuroinflammation via Regulation of ROS-Induced Oxidative Stress in PC12 and BV2 Cells

  2025cites this paper
• Acute Toxicity and Neuroprotective Effect of “RJ6601”, a Newly Formulated Instant Soup, in Geriatric Rats

  2025cites this paper
• The protective role of dexmedetomidine against anaesthetics-induced neurotoxicity through downregulating miR-34a

  2025cites this paper
• Global research trends of neuroinflammation in perioperative neurocognitive dysfunction: a bibliometric analysis

  2025cites this paper
• S100B Levels Following Administration of Thiopental and Fentanyl Midazolam Combination in Patients Undergoing Mechanical Ventilation: A Comparative Study

  2025cites this paper
• Synaptic plasticity and neuroprotection: The molecular impact of flavonoids on neurodegenerative disease progression.

  2025cites this paper
• The Search for Disease Modification in Parkinson’s Disease—A Review of the Literature

  2025cites this paper
• Evaluating brain and lens radiation exposure in interventional neuroradiology.

  2025cites this paper
• Oxidative Stress and Psychiatric Symptoms in Wilson’s Disease

  2025cites this paper
• Redefining Roles: A Paradigm Shift in Tryptophan–Kynurenine Metabolism for Innovative Clinical Applications

  2024cites this paper
• Ferroptosis and Cognitive Impairment: Unraveling the Link and Potential Therapeutic Targets.

  2024cites this paper
• Fasciculation potentials are related to the prognosis of amyotrophic lateral sclerosis

  2024cites this paper
• Gyosaponin ameliorates sevoflurane anesthesia-induced cognitive dysfunction and neuronal apoptosis in rats through modulation of the PI3K/AKT/mTOR pathway

  2024cites this paper
• 4-amino-3-(phenylselanyl) benzenesulfonamide attenuates intermittent cold stress-induced fibromyalgia in mice: Targeting to the Nrf2-NFκB axis.

  2024cites this paper
• Unveiling citicoline's mechanisms and clinical relevance in the treatment of neuroinflammatory disorders

  2024cites this paper
• Sequestration of oxidative is necessary but not sufficient enough to conclude dopaminergic neuroprotective efficacy of curcumin: Insights from ALSS Drosophila Parkinson’s disease model

  2024cites this paper
• Oxidative stress involvement in the molecular pathogenesis and progression of multiple sclerosis: a literature review

  2024cites this paper
• Sleep Deprivation in Early Life: Cellular and Behavioral Impacts.

  2024cites this paper
• Intermittent fasting alleviates postoperative cognitive dysfunction by reducing neuroinflammation in aged mice.

  2024cites this paper
• Inhaled Anesthetics: Beyond the Operating Room

  2024cites this paper
• Pyrazole-based N-phenyl pyrazolines: Synthesis, docking, and pharmacological evaluation

  2024cites this paper
• Therapeutic potential of saffron in brain disorders: From bench to bedside

  2024cites this paper
• Grifola frondosa polysaccharides alleviate Alzheimer's disease in rats

  2024cites this paper
• Pedunculoside alleviates cognitive deficits and neuronal cell apoptosis by activating the AMPK signaling cascade

  2024cites this paper
• Exploring the Effects of Natural Antioxidants in Neurodegenerative Diseases: A Comprehensive Review

  2024cites this paper
• Sevoflurane: an opportunity for stroke treatment

  2024cites this paper
• Neuroprotective Effects of STAT3 Inhibitor on Hydrogen Peroxide-Induced Neuronal Cell Death via the ERK/CREB Signaling Pathway

  2024cites this paper
• Quinic Acid Alleviates Behavior Impairment by Reducing Neuroinflammation and MAPK Activation in LPS-Treated Mice

  2024cites this paper
• The zebrafish gut microbiome influences benzo[a]pyrene developmental neurobehavioral toxicity

  2024cites this paper
• A combined X-ray fluorescence and infrared microspectroscopy study for new insights into elemental-biomolecular obesity-induced changes in rat brain structures.

  2023cites this paper
• Active constituents of saffron (Crocus sativus L.) and their prospects in treating neurodegenerative diseases (Review)

  2023cites this paper
• Impact of Plant-Derived Compounds on Amyotrophic Lateral Sclerosis

  2023cites this paper
• Effects of tetrahydroxy stilbene glycoside derivatives on free radical damage and apoptosis in APP695V717I transgenic mice

  2023cites this paper
• Protective Effects of Repetitive Transcranial Magnetic Stimulation Against Streptozotocin-Induced Alzheimer’s Disease

  2023cites this paper
• Oxidative Stress and Natural Antioxidants: Back and Forth in the Neurological Mechanisms of Alzheimer’s Disease

  2023cites this paper
• Resveratrol and its analogs suppress HIV replication, oxidative stress, and inflammation in macrophages

  2023cites this paper
• Effects of miR‐190a‐3p on Sevoflurane‐induced postoperative cognitive dysfunction (POCD)

  2023cites this paper
• Anti-Apoptotic and Anti-Inflammatory Properties of Grapefruit IntegroPectin on Human Microglial HMC3 Cell Line

  2023cites this paper
• Targeting neuroinflammation as a preventive and therapeutic approach for perioperative neurocognitive disorders

  2022cites this paper
• The developmental trajectories of the behavioral phenotype and neuropsychiatric functioning in Cornelia de Lange and Rubinstein Taybi syndromes: A longitudinal study

  2022cites this paper
• Inhibiting specificity protein 1 attenuated sevoflurane-induced mitochondrial stress and promoted autophagy in hippocampal neurons through PI3K/Akt/mTOR and α7-nAChR signaling.

  2022cites this paper
• Dietary total anti-oxidant capacity is inversely related to the prevalence of depression in adolescent girls

  2022cites this paper
• Glial cell reactivity and oxidative stress prevention in Alzheimer’s disease mice model by an optimized NMDA receptor antagonist

  2022cites this paper
• IGFBP-6: At the Crossroads of Immunity, Tissue Repair and Fibrosis

  2022cites this paper
• Neurobiological Promises of the Bitter Diterpene Lactone Andrographolide

  2022cites this paper
• A Pivotal Role of Nrf2 in Neurodegenerative Disorders: A New Way for Therapeutic Strategies

  2022cites this paper
• Three-Dimensional Quantitative Structure and Activity Relationship of Flavones on Their Hypochlorite Scavenging Capacity.

  2022cites this paper
• Recent progress on the role of non-coding RNA in postoperative cognitive dysfunction

  2022cites this paper
• Glutathione: A Samsonian life-sustaining small molecule that protects against oxidative stress, ageing and damaging inflammation

  2022cites this paper
• Proanthocyanidins alleviate pentylenetetrazole-induced epileptic seizures in mice via the antioxidant activity

  2022cites this paper
• HIV Dementia: A Bibliometric Analysis and Brief Review of the Top 100 Cited Articles

  2022cites this paper
• Plant-Based Polysaccharides and their Health Functions

  2021cites this paper
• Melatonin Successfully Rescues the Hippocampal Molecular Machinery and Enhances Anti-oxidative Activity Following Early-Life Sleep Deprivation Injury

  2021cites this paper
• WITHDRAWN: Assessment and Validation of Globodera pallida as a Novel In Vivo Model for Studying Alzheimer's Disease

  2021cites this paper
• Target Sestrin2 to Rescue the Damaged Organ: Mechanistic Insight into Its Function

  2021cites this paper
• Concepts of Neuroinflammation and Their Relationship With Impaired Mitochondrial Functions in Bipolar Disorder

  2021cites this paper
• Assessment and Validation of Globodera pallida as a Novel In Vivo Model for Studying Alzheimer’s Disease

  2021cites this paper
• Brain organoids: A promising model to assess oxidative stress‐induced central nervous system damage

  2021cites this paper
• A protective effect of curcumin on cardiovascular oxidative stress indicators in systemic inflammation induced by lipopolysaccharide in rats

  2021cites this paper
• Linking phytosterols and oxyphytosterols from food to brain health: origins, effects, and underlying mechanisms

  2021cites this paper
• Anticholinesterase activity and antioxidant properties of Heinsia crinita and Pterocarpus soyauxii in Drosophila melanogaster model

  2021cites this paper
• Urtica dioica extracts abolish scopolamine-induced neuropathies in rats

  2021cites this paper
• HIV-associated neurotoxicity and cognitive decline: Therapeutic implications.

  2021cites this paper
• Oxidative Stress in the Brain: Basic Concepts and Treatment Strategies in Stroke

  2021cites this paper
• Superoxide Dismutase-1 Intracellular Content in T Lymphocytes Associates with Increased Regulatory T Cell Level in Multiple Sclerosis Subjects Undergoing Immune-Modulating Treatment

  2021cites this paper
• Nanotechnology as a therapeutic strategy to prevent neuropsychomotor alterations associated with hypercholesterolemia.

  2021cites this paper
• Inflammation, oxidative stress, insulin resistance, and hypertension as mediators for adverse effects of obesity on the brain: A review

  2021cites this paper
• Going the Extra (Synaptic) Mile: Excitotoxicity as the Road Toward Neurodegenerative Diseases

  2020cites this paper
• Polyphenols from Thelesperma megapotamicum and Their Antioxidant and Neuroprotective Activities

  2020cites this paper
• Acetate attenuates perioperative neurocognitive disorders in aged mice

  2020cites this paper
• Effect of dietary resveratrol on cell-mediated immunity and hepatocyte morphometry in the model organism medaka (Oryzias latipes Temminck & Schlegel)

  2020cites this paper
• Immunotherapy for Parkinson’s disease

  2020cites this paper
• Comparison the Effect of Propofol and Thiopental on Patient Prognosis after Severe Traumatic Brain Injury

  2020cites this paper
• Comparison of the calcium-related factors in Parkinson’s disease patients with healthy individuals

  2020cites this paper
• Characterization and Antioxidant Activity Determination of Neutral and Acidic Polysaccharides from Panax Ginseng C. A. Meyer

  2020cites this paper
• Long term treadmill exercise affects age-related oxidative stress in the spinal cord of rats

  2020cites this paper
• Pharmacological evaluation of hydro-ethanol and hot water leaf extracts of Bauhinia galpinii (Fabaceae): A South African ethnomedicinal plant

  2020cites this paper
• Gallic acid prevents ketamine-induced oxidative damages in brain regions and liver of rats.

  2020cites this paper
• S-Allylcysteine Protects Against Excitotoxic Damage in Rat Cortical Slices Via Reduction of Oxidative Damage, Activation of Nrf2/ARE Binding, and BDNF Preservation

  2020cites this paper
• Differential immunogene expression profile of European sea bass (Dicentrarchus labrax, L.) in response to highly and low virulent NNV.

  2020cites this paper
• Laser ablation for pharmaceutical Nanoformulations: Multi-drug Nanoencapsulation and Theranostics for HIV.

  2020cites this paper
• Bisdemethoxycurcumin exerts a cell-protective effect via JAK2/STAT3 signaling in a rotenone-induced Parkinson's disease model in vitro.

  2020cites this paper
• Impact of covalent or non-covalent bound epigallocatechin-3-gallate (EGCG) on assembly, physicochemical characteristics and digestion of ovotransferrin fibrils

  2020cites this paper
• Protective Effect of Protocatechuic Acid, Phenolic Compound of Momordica Charantia, against Oxidative Stress and Neuroinflammation in C6 Glial Cell

  2020cites this paper
• Molecular Signature of the Immune Response to Yoga Therapy in Stress-related Chronic Disease Conditions: An Insight

  2020cites this paper
• Exercise-driven restoration of the alcohol-damaged brain.

  2019cites this paper
• Peri-operative Cognitive Alterations and the Ageing Brain

  2019influential citation
• NADPH Oxidase 2-Mediated Insult in the Auditory Cortex of Zucker Diabetic Fatty Rats

  2019cites this paper
• An overview on recent in vivo biological application of cerium oxide nanoparticles

  2019cites this paper
• Assessment of Tiron as a cardioprotective agent

  2019cites this paper
• Cholesterol Sulfate Alters Astrocyte Metabolism and Provides Protection Against Oxidative Stress.

  2019cites this paper
• Anti-embolic and anti-oxidative effects of a novel (E)-4-amino-N′-(1-(7-hydroxy-2-oxo-2H-chromen-3-yl) ethylidene) benzohydrazide against isoproterenol and vitamin-K induced ischemic stroke

  2019cites this paper
• Tyrosol, a simple phenol from EVOO, targets multiple pathogenic mechanisms of neurodegeneration in a C. elegans model of Parkinson's disease.

  2019cites this paper
• Lanthanum chloride induces neuron damage by activating the nuclear factor-kappa B signaling pathway in activated microglia.

  2019cites this paper